BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Jul 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-07-27

Reporting Person: Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-06	Common Stock	G	12000.0000	$0.0000	Disposed	238780.0000	Direct
2021-07-27	Common Stock	M	70306.0000	$6.2800	Acquired	309086.0000	Direct
2021-07-27	Common Stock	S	105490.0000	$45.0031	Disposed	203596.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-27	Stock Option (Right to Buy)	$6.2800	M	70306.0000	Disposed	2022-02-27	Common Stock (70306.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	68258.0000	Indirect
Common Stock	6038.0000	Indirect

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.

F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.